NEW YORK, Jan. 5, 2018 /PRNewswire/ -- DFB Healthcare Acquisitions Corp. ("DFB Healthcare") announced today that it has fileda registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of its securities. DFB Healthcare plans to list its securities on the NASDAQ Stock Market.
DFB Healthcare is being
Goldman, Sachs & Co. and Deutsche Bank Securities will be the underwriters of the securities offering. A registration statement relating to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time that the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The registration statement can be obtained at www.sec.gov.
About DFB Healthcare Acquisitions Corp.
DFB Healthcare Acquisitions Corp is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It has not identified any business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with respect to identifying any business combination target. Its acquisition and value creation strategy will be to identify and acquire a business in the healthcare sector.
The offering will be made only by means of a prospectus. Copies of the preliminary prospectus related to the offering may be obtained, when available, from Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, NY 10282, or by telephone toll-free at 1-866-471-2526 or by email at firstname.lastname@example.org and from Deutsche Bank Securities Inc., Attention: Prospectus Group, 60 Wall Street, New York, New York 10005-2836 (Tel: (800) 503-4611; Email: prospectus.CPDG@db.com).
DFB Healthcare Acquisitions Corp. Chris Wolfe, (212) 965-2400 email@example.com
View original content:http://www.prnewswire.com/news-releases/dfb-healthcare-acquisitions-corp-files-registration-statement-for-initial-public-offering-of-securities-300578226.html
SOURCE DFB Healthcare Acquisitions Corp.
Subscribe to our Free Newsletters!
Fallopian tube cancer is a form of gynecologic cancer arising in the fallopian tubes, which are ...
Cushing syndrome is a collection of symptoms caused due to excessive amount of cortisol in the body ...
CAR T-cell therapy is a type of gene therapy where the patient's T-lymphocytes are genetically ...View All